Together, the clear separation of curves, highly significant log-rank P values, and hazard ratios substantially below 1.0 provide congruent and compelling evidence that vancomycin TDM is associated with significantly improved survival outcomes in critically ill patients.
← all excerpts
Vancomycin therapeutic drug monitoring is associated with reduced toxicity in ICU patients: a MIMIC-IV retrospective study.
1
—
—